Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for nemolizumab in moderate-to-severe atopic dermatitis is now displayed, including study design, eligibility criteria, locations, outcome measures, and record history. The page also provides the study protocol and statistical analysis plan.
    Difference
    100%
    Check dated 2026-11-11T02:07:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:35:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s terminology transition appears above the study page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:34:25.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:43:43.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with minimal navigation (including a Home link). The previously visible study details are replaced by this error page.
    Difference
    17%
    Check dated 2026-09-23T00:51:54.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.6 to v3.7.0. This indicates a newer version of the study documentation rather than a substantive change to the study content.
    Difference
    0.0%
    Check dated 2026-09-16T00:06:03.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.